GeneTex

  • Country / Location Selection

United States (US)

F1A alpha peptide

Cat. No. GTX26098

Application

 Neutralizing/Inhibition

Species

 Human
Package
50 μg ($139)
See all FEM1B products

APPLICATION

Application Note

The peptide is used for blocking the antibody activity of anti-F1A alpha (cat. No GTX23686). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 30 min at 37ºC.

PROPERTIES

Form

Liquid

Buffer

PBS, 0.1% BSA

Preservative

0.02% Sodium azide

Storage

Store the peptide at -20ºC, stable for one year.

Concentration

0.20 mg/ml (Please refer to the vial label for the specific concentration.)

Conjugation

Unconjugated

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

Fem-1 Homolog B , F1A-Alpha , F1Aa , Fem1-Beta , Fem1B

Background

F1A alpha, also termed FEM1 beta, is a novel protein that associates with the intracellular domains of Fas and TNFR1. Over expression of F1A alpha induces apoptosis. F1A alpha also associates with CED-4 and its mammalian homologue Apaf-1, and can be cleaved by CED-3 and caspases.

Research Area

REFERENCE

There are currently no references for F1A alpha peptide (GTX26098). Be the first to share your publications with this product.
Submit a Reference

REVIEW

There are currently no reviews for F1A alpha peptide (GTX26098). Be the first to share your experience with this product.
Submit a Review
SDS
PBS.pdf
Sodium Azide.pdf
Package List Price ($)
$ 139